307 related articles for article (PubMed ID: 21752533)
1. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.
Margulis V; Master VA; Cost NG; Leibovich BC; Joniau S; Kuczyk M; Mulders PF; Kirkali Z; Wirth MP; Hirao Y; Rawal S; Chong TW; Wood CG
Eur Urol; 2011 Oct; 60(4):673-83. PubMed ID: 21752533
[TBL] [Abstract][Full Text] [Related]
2. Lymph node dissection in renal cell carcinoma.
Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
[TBL] [Abstract][Full Text] [Related]
3. The role of lymph node dissection in renal cell carcinoma.
Delacroix SE; Chapin BF; Wood CG
Urol Clin North Am; 2011 Nov; 38(4):419-28, vi. PubMed ID: 22045173
[TBL] [Abstract][Full Text] [Related]
4. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
5. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.
Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G
Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
Sun M; Shariat SF; Cheng C; Ficarra V; Murai M; Oudard S; Pantuck AJ; Zigeuner R; Karakiewicz PI
Eur Urol; 2011 Oct; 60(4):644-61. PubMed ID: 21741163
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma: presentation, staging, and surgical treatment.
Russo P
Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment for renal cell carcinoma].
Roos FC; Rübben H; Stief C; Stöckle M; Thüroff JW
Aktuelle Urol; 2010 Jul; 41(4):252-6. PubMed ID: 20661841
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
14. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.
Moch H; Artibani W; Delahunt B; Ficarra V; Knuechel R; Montorsi F; Patard JJ; Stief CG; Sulser T; Wild PJ
Eur Urol; 2009 Oct; 56(4):636-43. PubMed ID: 19595500
[TBL] [Abstract][Full Text] [Related]
15. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
16. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
17. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back.
Margulis V; Wood CG
Cancer J; 2008; 14(5):308-14. PubMed ID: 18836335
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for presurgical therapy for renal cell carcinoma?
Calabrò F; Sternberg CN
Expert Rev Anticancer Ther; 2010 Jun; 10(6):807-12. PubMed ID: 20553206
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
Margulis V; Sánchez-Ortiz RF; Tamboli P; Cohen DD; Swanson DA; Wood CG
Cancer; 2007 May; 109(10):2025-30. PubMed ID: 17420980
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
